by Leonard G. Horowitz, D.M.D., M.A., M.P.H.
from
OriginOfAids Website
This article regards a
matter of global urgency transcending better known AIDS threats.
It
describes a universal challenge posed by ever increasing numbers of
plagues predicted to depopulate at least half of the world’s current
human inhabitants within two generations. This documented science
virtually proves, through the process of elimination and a review of
the most updated evidence, the origin of HIV/AIDS as an iatrogenic
(i.e., man-made) outcome of specific vaccination experiments.
Considered reflection on this AIDS science, along with the
sociopolitical correlates and antecedents of this current
catastrophe, reveals the likelihood that myriad other immune
dysfunctions, autoimmune diseases, and cancers, including leukemias,
lymphomas, sarcomas, and other ailments linked to viral infections,
have resulted from previously engineered microbes that have by
accident or intent found their way from cancer virus laboratories
into humanity’s bloodstream by way of the most trusted public health
preventative - vaccinations.
If what you are about to read is true, and each point is precisely
stated and meticulously documented, beyond extensive depopulation,
humanity’s very survival may hinge on this recognition, its
implications, and our considered response.
Especially relevant,
when reflecting on the following facts, is the wisdom addressed by
the late World Health Organization (WHO) AIDS czar, Dr.
Jonathan Mann, whose life ended tragically on Flight 111 enroute
to a European AIDS conference.
“More than a medical
scientific problem,” Dr. Mann said, “AIDS is a sociopolitical
imposition.”
Background
AIDS is undoubtedly “man-made.”
We can now assert this “very
apparent iatrogenic origin,” versus the “theoretic iatrogenic
origin” of HIV/AIDS because of the rapidly increasing, now
substantial, scientific support for this conclusion.
Currently, international
scientific consensus among leading investigators in this field, many
of whose works and words are excerpted below, holds that HIV/AIDS
originated from one or more extraordinary man-made, not natural,
events dating back to the early to mid-1970s. Especially implicated
in initiating the AIDS pandemic, according to many scientists and
scholars, was the hepatitis B vaccine as detailed below.
This may come as a surprise, or even quite a shock, to most people
since the mainstream media and most respected medical journals have
yet to herald the following knowledge.
As a result most
“authorities” still issue false and misleading claims such as:
-
“the HB vaccine
theory of HIV/AIDS origination has been discussed, debated,
and dismissed by an overwhelming majority of the HIV/AIDS
research community”
-
“People who
claim that AIDS was man-made provide false information and
hearsay”
-
“It is sad that
public attention and resources are diverted to attend to
such unscientific dribble”
-
“Man-made origin
of AIDS vaccine proponents do severe damage to the public
health community and vaccination efforts”
-
“Those that
advance man-made theories of AIDS have financial motives,”
as though there were no financial interests on the other
side of the debate
As a pro bono consultant
contacted recently by Amnesty International (AI) members who desired
to advance a resolution for the global organization to investigate
this HB vaccine thesis, I was appalled by the amount of resistance
and politicking performed by members of AI’s so-called “HIV/AIDS
Task Force” which sought $1 billion of relief for human rights
violations associated with HIV/AIDS from the U.S. Government.
These funds, the Task
Force reported, were urgently needed to buy drug-cocktails for
persons with HIV/AIDS. Each of the five claims cited above were
issued by members of this Task Force completely ignorant of the
following science.
With regard to the first offensive claim, as the sole author of
“Polio, hepatitis B and AIDS: an integrative theory on a possible
vaccine induced pandemic” published by Harcourt Publishers, Ltd. of
London in the esteemed international journal of Medical Hypothesis,2
this well-focused thesis has never been “discussed, debated,” nor
“dismissed” by any consensus in any official capacity.
Although Black Americans
have been polled regarding the origin of HIV/AIDS being man-made,3
there has never been a published polling of the scientific community
in this regard, and certainly not one regarding the HB hypothesis
advanced below.
HIV/AIDS
Origin Misconceptions Versus Science
Opponents of iatrogenic (or “man-made”) theories of AIDS have
routinely confused hearsay and sporadic media propaganda with hard
science, such as that “discussed, debated” and not “dismissed”
recently at the Royal Society of London’s inquiry into the origin of
this pandemic.
They exclusively focused on the theory that
contaminated polio vaccines triggered the HIV/AIDS pandemic.4
These proceedings were
published in 2001. Quotes relevant to reasoned consideration of this
unique/yet-to-be-tested hepatitis B vaccine theory of HIV/AIDS
follow. These statements were made by featured presenters, all
recognized leaders in this multidisciplinary field discussing the
polio vaccine theory of AIDS origination.
The first of these
quotes is especially relevant to proposed investigations:
“There should be an
investigation by an international committee mostly composed of
non-medical people concerning how a rather obvious and plausible
theory [of AIDS’s origin from contaminated vaccines] came to be
scorned and restricted from publication for so long, especially
when important consequences regarding mankind’s worst epidemic,
and even more important consequences for other possibly even
worse that may be following, hang in the balance.
As a corollary it
should be studied why the hypothesis had to be promoted mainly
by outsiders to science and medicine. The reassures towards
investigation (and non-investigation) that emanate from huge
drug companies and their influence in slanting research in
subtle ways should also be examined, as should the role of
journals and peer review in potentially obstructing publications
of controversial kinds.”
W.D. Hamilton,5
quoted by Julian Cribb in “The origin of acquired immune
deficiency syndrome: can science afford to ignore it?” Phil.
Trans. R. Soc. Lond. B (2001) 356:935-938.
“Faced with the
terrible burden of AIDS, stories that HIV was introduced into
Africa from the West by an accident such as OPV [oral polio
vaccine] or intentionally by the USA Central Intelligence Agency
(CIA) have gained widespread credence...
Nevertheless,
because natural transmission repeatedly occurs, albeit on rare
occasions, does not mean that contamination of a vaccine could
not have been the route on another occasion. As with other
infections, e.g., hepatitis B virus, natural and iatrogenic
transmissions of retroviruses are not mutually exclusive.”
Weiss, RA6
Despite studies that
have advanced evidence suggesting an earlier than 1970 origin of
HIV/AIDS
7-9,
“[t]he fact that
there were ten or so synchronous but distinguishable African
epidemics is a definitive feature of AIDS for which the natural
transfer theory [e.g., the “cut hunter transfer”] gives no
convincing account...
To summarize these findings regarding the
relatively large number of distinct group M subtypes: no set of
likely natural conditions... will adequately simulate so many as
ten distinguishable subtypes in a complex star-like
configuration... [T]he onus is upon the supporters of the
natural [not iatrogenic] theory to account for the unexpectedly
large number of HIV-1 subtypes. Exponential growth of the
epidemic(s) is not by itself a satisfactory explanation
(Hahn et al.
2000)....
The likeliest source
of the multiple subtypes and the synchronization of their
conspicuous diversification is a punctuated origin [i.e., an
iatrogenic event].... [I]t is not far-fetched to imagine the ten
or so clades deriving from a single animal (perhaps immuno-suppressed
and possessing a swarm of variants) [as might have been the case
with chimpanzees used in the process of vaccine manufacture] or
from a few animals that might have belonged to a single troop or
might have been gang-caged together.
The number of animals
required is secondary to the extent of variation in the source
at the time of the zoonotic [i.e., transfer of the virus between
species] or iatrogenic event. The [vaccine] hypothesis makes a
case for such a punctuated origin . . .”
Myers G, et al.
10
“We conclude that SIV cannot become a zoonosis, but requires
adaptive mutations to become HIV. Some modern event must have
aided in the transition of SIV to HIV. Our research indicates
that serial passage of partially adapted SIV between humans
could produce the series of cumulative mutations sufficient for
the emergence of epidemic HIV strains...
We conclude that
increased unsterile injecting in Africa during the period
1950-1970 provided the agent for SIV human infections to emerge
as epidemic HIV in the modern era.”
Drucker E, et al.11
I might interject at
this point that this conclusion by Drucker et al, although
seriously undermining natural evolution theorists, reflects a myopic
arrogance unbecoming to their otherwise reasonable hypothesis.
Their
conclusion neglects the risks inherent in the hepatitis B vaccine
manufacturing and testing process as detailed below consistent with
the analyses of Myers et al.10
Obviously, all of the above authoritative statements contradict
“common knowledge.”
The consensus of
scientists at this historic British AIDS origin conference favored
additional investigations into possible iatrogenic sources of the
HIVs.
The 1959 HIV
Sequence Discovery
In the interest of facilitating progress on this issue, much
publicity has been given to the notion that HIV was discovered in a
1959 blood sample from Leopoldville, Zaire;8
and that scientific consensus holds 1931 as the approximate date of
HIV origination.7
These superstitions have led to common, yet false, declarations that
HIV/AIDS originated well before the polio vaccination era and the
Special Virus Cancer Program (SVCP) that much evidence below links
to the “punctuated origin” of AIDS.
For the record, according to the authors of the 1959 discovery, they
never found, nor alleged to have found, HIV, or anything like a full
virus. According to these authors, even,
“attempts to amplify HIV-1
fragments of >300 base pairs (bp) were unsuccessful,... However,
after numerous attempts, four shorter sequences were obtained” that
only represented small portions of two of the six genes of the
complete AIDS virus.9
This is why Gao et al, referred to the 1959 sequences as,
“the oldest trace of
the AIDS pandemic... although the precise timing and
circumstance of early events in the SIVcpz/HIV-1 zoonosis remain
obscure.”
22
[Editor’s note
for the lay reader, “SIVcpz” is short for “simian
immunodeficiency virus from the chimpanzee.” This is know to be
the closest viral relative to the human AIDS virus, HIV-1.]
Unfortunately, regarding
the 1959 sequences, Zhu et al., left much room for misinterpretation
if not wild speculation by stating that given the,
“‘starburst
phylogeny,’ HIV-1 was probably introduced into humans shortly
before that time frame, about a decade or two earlier than
previously estimated...”
10
They speculated the
zoonosis might have occurred “considerably earlier than the late
1940s.” Obviously, this account is irrelevant to “the extraordinary
synchrony in the 1970s of ten or more distinguishable epidemics”
discovered by Myers et al. 10
Therefore, this later group of
researchers concluded that, with the exception of the 1959 sequences
suggesting viral ancestry,
“Clinical,
serological and molecular retrospective studies have all failed
to produce any evidence of AIDS or HIV prior to the 1970s.”
10
As Myers et al., had
initially advanced, the early to mid-1970s “Big Bang” origin of
HIV/AIDS is further supported by most recent scientific evidence.10
As if repeating false assumptions would alter historic and
scientific facts, many contemporary investigators, like those
representing AI’s HIV/AIDS Task Force, continue to imply the SIV to
HIV zoonosis occurred on or before 1959. Many natural evolution
theory evangelists continue to cite the now disproven “cut hunter”
theory to explain the origin of the pandemic.8,
22
Reflecting on Zhu et al’s position, however, they simply concluded that the major-group
viruses that dominate the global AIDS pandemic at present shared a
common ancestor in the 1940s or the early 1950s.
However, given
confounding factors, including the likelihood of viral gene
recombination during the manufacture and testing of the HB vaccine,
like Korber et al.’s speculation discussed in the next section, the
1959 “isolate” may hold little, if any, relevance in determining the
origin of HIV/AIDS.
10
Suffice it to say, no one has ever found a virus predating the SVCP
and the late 1970s.11
At best they found fragments of what may have been the complete
virus, but more likely pieces of a progenitor virus they called “a
common ancestor” that dated back to “the 1940s or the early 1950s.”
These and other portions of this “common ancestor” may have existed
for centuries if not millennia. Again, this evidence is irrelevant
when considering the 1970s “punctuated [iatrogenic] event” recently
determined to be undisputable scientific fact.
More importantly, as Zhu and Ho et al., concluded,
“the role of
large-scale vaccination campaigns, perhaps with multiple uses of
non-sterilized needles, should be carefully examined,...” as
contributing to the sudden emergence of HIV/AIDS in North
America and Africa simultaneously during the late 1970s.9,
11
The 1931 AIDS
Origin Assumption and Viral Recombination
Regarding the 1931 estimated date of HIV’s origin advanced by Korber
et al.7 (i.e., “somewhere between 1910 and 1950”), a critical
examination of these authors’ methods reveals problems.
Largely
speculative due to their use of a confounding-factor-liable computer
model, Korber and colleagues noted their limitations. They stated
their finding(s) regarding the 1931 genetic projection, that
precludes various vaccine-induced pandemic theories, might be wrong
if viral recombination(s) had occurred. They most certainly did in
the evolutionary process of SIV to HIV according to most cientists.10,
13
Yet, despite these
facts, iatrogenic theory opponents who have secured a gross burden
of proof” advantage in the AIDS origin debate,20
repeatedly reference this group’s work, along with the frequently
misrepresented work of Zhu, et al.9
concerning the 1959 sequence discovery.22
Again, the “punctuated origin” of HIV/AIDS determined by Myers et
al., can only explain the nearly simultaneous emergence of ten
separate, though related, AIDS epidemics in Africa during the early
1970s, that were well established by 1976.10
Lending further credence to the theory that early hepatitis B
vaccine trials provided the “punctuated event,” Korber et al wrote
of anticipated errors in their 1931 determination using linear or
recombinant evolutionary models due to “unnatural” or iatrogenic
events inciting viral recombination.
They wrote ,
“If there was a
concentration of such recombinants during just one period of
sampling, the effect on the timing estimate would be
unpredictable.”
7
Thus, if the “punctuated
origin event” advanced by Myers et al,10 had been the passage of HB
virus from polio vaccinated humans to chimpanzees then back to
humans, with the additional risk of recombination from pooling
hundreds of infected serum samples prior to additional viral
recombinant transfers via the HB vaccines given to human subjects in
New York City and sub-Saharan Africa, then this might best explain
the origin of HIV/AIDS and render Korber et al’s 1931 projection
inconsequential.
As detailed in the next section, this is precisely
the thesis advanced by Horowitz.2,
13
In summary, the determinations reached by Korber et al.,7
and Ho et al.,9
of possible dates for the origin of HIV-1, 1931 and 1959
respectively, have been adequately clarified elsewhere.10
“The
authors themselves acknowledge, the super-computer-based study
cannot tell whether this hypothetical 1930 virus was in humans or
animals and so do not show when zoonosis occurred.”
7, 10
Myers et al. further qualified:
“If PIV [primate
immunodeficiency virus] was in humans in the first half of the
20th century, it may be estimated, given the assumptions of the
look-back analysis, that the ancestral HIV-1 group M virus arose
at 1930 plus or minus 20 years.”
Conversely, if PIV was
not in humans in the first half of the 20th century, then the Korber
et al analysis holds little, if any, value in-so-far-as determining
a date or origin of the HIVs and AIDS.
7, 10
The Earliest
Hepatitis B Vaccines and The Origin of AIDS
If early polio vaccines had not triggered the origin of HIV/AIDS as
scientific consensus now holds,6 then some other,
chimpanzee-related, “iatrogenic event” must be available to explain
the staggering array of deadly recombinants that were proven by
Myers et al to have arisen virtually simultaneously during the early
to mid-1970s.10,21
In this regard, even more neglected, and perhaps
more relevant than the OPV theory of AIDS, is the hepatitis B (HB)
vaccine hypothesis.2,13,23
According to scientific records,2
African chimpanzees were used in the manufacture of the HB vaccines
during the early 1970s. Additional documents prove that human HB
viruses cultured in vivo in chimpanzees were returned to humans
whose infected blood serum was then pooled to develop four different
strains of experimental HB vaccine pilot tested between 1970 and
1975 in New York City and central Africa.
This HB vaccine theory
of HIV zoonosis proposes that endogenous, or more likely exogenous,
progenitor viruses were activated24
when serially transmitted from humans to chimpanzees, then back to
humans.
Subsequently, pooled blood serum containing HB surface
antigen and/or live virions, a milieu ripe for viral recombination,
was used to develop the four suspected vaccines administered to New
York’s gay population and simultaneously to sub-Saharan Africans.
Besides the phylogenetic evidence cited above, epidemiological
evidence also supports this HB vaccine theory of HIV/AIDS
origination.
Figure 1 is derived from
Higginson and Muir’s report on cancer studies conducted by the
International Agency for Research in Cancer (IARC) in collaboration
with the National Cancer Institute (NCI).25
Figure 2 derives from
this data superimposed on a map of HIV-1 seroprevalence in Africa
reported by the U.S. Department of Commerce in a publication
discussing desirable depopulation associated with HIV/AIDS.26
Additional evidence here
was supplied in the chronology of the early hepatitis B vaccine
trials compiled by Goodfield.27
The two maps, juxtaposed, show a striking correlation between
hepatitis B vaccine and liver cancer experiments conducted in Africa
during the early 1970s, and the countries in central and southern
Africa with the highest HIV-1 seroprevalence rates by 1994. The
black squares indicate areas participating in the HB cancer virus
research and vaccine trials.
It should also be noted that Mozambique has one of the highest rates
of HIV-2, which was allegedly discovered by Essex et al.,28
in Senegalese female prostitutes years after the African hepatitis B
vaccination pilot studies began. Due to their state-authorized
employment and high risk for infection, Senegalese female
prostitutes were required to receive hepatitis B vaccinations for
relic ensure.
That Essex et al. found SIVagm, a documented vaccine
contaminant, in the blood of these human subject, is additionally
compelling evidence in support of the HB vaccine AIDS origination
theory.29
In brief, a well documented, theoretically viable, and generally
neglected evolutionary route of SIVagm to HIV-1 zoonosis
sequentially involves:
-
Polio vaccine
recipients worldwide, including gay men in New York, and
Blacks in Central Africa, were exposed to simian viruses
including SV40, SFR (Simian Foamy Retroviruses containing
reverse transcriptase), SIVagm, and perhaps others from the
mid-1950s, through at least the 1960s;2,
4
-
Between 1965 and
1970, researchers in NYC “isolated” and then inoculated the
MS-2 strain of HB virus into the above cited New York and
African HB vaccine study “volunteers.”
2, 30
-
Human derived HB
viruses, and potentially activated retroviral sequences,
were then transferred to chimpanzees, then back again to
humans in NYC and central Africa during the development and
testing of four genetically altered subtypes of the pre-1975
experimental HB vaccine.32,
33
HIV-1 progenitor
contamination, recombination, and/or transmission risks were likely
increased during this process by:
-
human incubation
for more than a decade of polio vaccine contaminants and
recombinants including SV40, SFR, and possibly SIVagm
-
the pooling of
infected blood serum donated by hundreds of gay American and
Black African polio vaccine recipients who had subsequently
received injections with chimpanzee cultured strains of HB
virus
-
the biohazardous
laboratory conditions and viral containment problems
reported by the HB vaccine investigators and their
affiliates
-
the four pooled
serum-derived HB vaccines that were administered to
thousands of test subjects by 1975, primarily gay males in
NYC and central African Blacks.
This series of events
provides the best explanation for an early to mid-1970s
“punctuated origin event” most precisely fitting the
etiological determinations of the HIV-1/AIDS pandemic
10
Again, it should be
noted that the African “volunteers” inhabited a geographic area
consistent with the highest rates of HIV-1 seroprevalence. Among the
nations where rates are highest, HB studies were conducted in:
Senegal, Cote d’Ivoire, Uganda, Kenya, Swaziland, and the
northeastern part of South Africa.
According to
circumstantial evidence, eastern Zaire bordering the West Nile
region of northwest Uganda also hosted such trials.2,
25-27
Historic
Precedence for the HB Vaccine Hypothesis
There is historic precedence for this precise HB thesis. According
to Beale, the risk of HB viruses contaminating human blood serum and
subsequent vaccinations was determined as early as 1942. Then, more
than 62 deaths and 28,500 cases resulted from serum HB contaminated
yellow fever vaccines.31
According to Hilleman, early yellow fever vaccines also delivered
leukemic retroviruses to human populations due to caged animal and
laboratory contaminations and concomitant vaccine transmissions.13
Dr. Hilleman additionally reinforced this “punctuated origin” thesis
by describing the risks he encountered by importing contaminated
African sub-human primates for vaccine research and development at
the Merck pharmaceutical company.
Between the late 1950s through the
1970s, Dr. Hilleman told Harvard medical historian Edward Shorter in
1987,
“I brought African
greens in. I didn’t know we were importing AIDS virus at the
time.”13
Given these statements
of fact, it is reasonable to suggest, as stated above, the earliest
HB vaccine pilot studies may have activated an endogenous or
exogenous HIV-related retroviral gene in one or more of the
primates,24
fulfilling the “starburst phylogeny” antecedents advanced by Myers
et al.10
During the Royal Society’s symposium on the origin of AIDS, Hooper’s
1950s OPV/AIDS hypothesis was largely rebuked because he failed to
establish the use of chimpanzees by the Wistar Institute in the
production of the suspected OPV.18
Moreover, this vaccine was not given selectively to New York’s gay
male population.
Curiously, Merck’s early
1970s hepatitis B vaccine trials that did involve gay men in NYC,
and Blacks in central Africa, partially prepared in Litton Bionetics
(LB) exported/Merck imported African chimpanzees, ironically went
without mention.
“Burden of
Proof” and the Origin of AIDS
The most vocal opponent of the OPV and HB vaccine theories of
HIV/AIDS origination is Dr. John Moore, affiliated with Rockefeller
University’s Aaron Diamond Research Center in New York.
As reported in Medical Hypothesis, following a presentation
advancing the HB vaccine theory of HIV/AIDS at the XI International
Conference on AIDS, in 1996, Dr. Moore flippantly rebuked this
thesis in the Canadian press. A few years later, he did the same
regarding the Edward Hooper’s book,
The River, which he alleged was
historically inaccurate, potentially damaging to the public’s trust
in western medicine, and harmful to his colleagues “efforts to make
AIDS vaccines for use in Africa.” 2
When this author personally contacted Dr . Moore in an effort to
begin scientific discourse following his Canadian press interview,
Moore refused any formal discussion.
Responding later to
prodding, he wrote me from the Aaron Diamond AIDS Research Center
saying,
“I explicitly denied
you an interview when you requested one... I said to you that I
had ‘no interest’ in you... grotesque theories... For the
record, I know what your views are, and I reject them. Indeed, I
dismiss them as uninteresting, incorrect and downright stupid.”
In the Vancouver Sun,
Moore was further quoted as saying,
“HIV is transmitted
from monkeys to humans. I don’t think there’s any doubt about
that. It’s hard scientific reality.”
In fact, according to
scientific consensus, the defining zoonosis for the origin of HIV
occurred between chimpanzees and humans, not monkeys.2
It should be noted that Dr. Moore’s institutional benefactors
include
the Rockefeller family which, along with the Rockefeller
Foundation and its institutional affiliate - the Sloan-Kettering
Memorial Cancer Center in New York - has heavily invested in viral
cancer research, vaccine developments, propaganda programs,
population control efforts, and the Merck pharmaceutical company in
particular. Thus, Moore’s bias is strongly suggested.2,13,14
Worse yet, history shows that soon after Dr. Gallo’s alleged
“discovery” of the AIDS virus in 1984, Dr. Moore co-directed the
only official effort to examine Merck’s HB vaccine for “fear of
possible AIDS transmission.” 23
His principle co-investigator was Dr. B.J. Poiesz at the State
University of New York.
Dr. Poiesz, their paper
noted, had worked closely with Dr. Gallo in isolating the “type-C”
cancer virus associated with lymphomas during the mid to late-1970s.
Their group of researchers included “anonymous CDC authors” who, for
unspecified reasons, omitted the centrally important New York City
and African HB vaccine recipients from their analysis.
Adding insult
to this injury, the team’s conclusions were entirely inconsistent
with earlier epidemiological
determinations and serological measures.13
Reinforcing the observance of such political bias and tainted
science in this field of inquiry is the conclusion reached by
several featured speakers at the Royal Society’s meeting in London.
They addressed the “burden of proof” required of iatrogenic versus
natural AIDS origin theorists.
10, 19, 20
These experts protested the unfair unscientific advantage that has
been historically given to outspoken natural evolution theorists,
such as Dr. Moore, who have been curiously exempt from having to
substantiate their obviously flawed claims and hypotheses.
Ironically, despite this, their unproven misguided theories remain
widely accepted as supposed fact.10,
19, 20
The only remedy such deception is updated knowledge regarding the
advanced genetic analyses that have seriously undermined arguments
for isolated viral leaps that cannot adequately explain the source
of AIDS and the “sunburst phylogeny” of HIV’s earliest African
strains.10
In the wake of the Royal
Society’s symposium, theories that now appear tenuous, if not
ludicrous, include isolated parenteral (i.e., skin piercing)
injuries (e.g., the “cut hunter theory”), nutritional exposures,
population movements, and climatic variations that are alleged to
have led to isolated zoonotic events followed years later,
evolutionarily, by the spreading plague.
Alternatively, many
participants at the conference concluded that,
"the transfer of SIV
to human beings was probably connected with unprecedented
medical activity in Africa in the 20th century.”21
Bionetics
Evidence to be Reconciled
What continues inadequately reported in the scientific literature,
perhaps because researchers remain unaware, or because most
investigators would certainly feel threatened by such disconcerting
revelations, was that the precise scenario advanced by Myers et
al.,10 to best account for the sunburst phylogeny and “punctuated
origin” event was repeatedly engineered and studied during the
Litton Bionetics (LB) administered SVCP, at precisely the time
(1969-1974) required to produce the “Big Bang,” as Myers originally
called it.
At this same time, LB’s
study of HB viral co-infections with viruses currently linked to
HIV-related immune suppression and AIDS symptomatology was ongoing,
as you will read below. This information comes directly from their
contract titled, “Investigations of Viral Carcinogenesis in
Primates” (NIH Grant Number 71-2025 beginning February 12, 1962).
This team, officiated by
NCI “Project Officer” Dr. Robert Gallo, the subsequent discoverer of
HTLV-1,2
(leukemia viruses) and HIV-1 (the AIDS virus) almost 15 years later,
stated:
“During the past
year [1970] macaques were inoculated at birth or in utero with
the Mason-Pfizer monkey mammary virus, Epstein-Barr virus (EBV),
Herpesvirus saimiri, and Marek’s disease virus. EB virus was
given with immuno-stimulation and immuno-suppression (ALS,
prednisone, imuran). Australian antigen [HB virus] was given to
newborn African green monkeys.”
Might this quoted
knowledge have impacted Dr. Gallo’s earliest declaration that the
origin of HIV-1 came from “African greens” (i.e., SIVagm), and/or
Dr. Hilleman’s confession that he brought the AIDS virus into North
America in African greens?
Furthermore, it is well known that HIV-2 sources from macaque
monkeys from this same time period.8 Might this specific
multiply-infected simian colony be the source of the original SIV to
HIV zoonosis? There is much evidence to suggest this, and it is
certainly worthy of an official inquiry.
It is also curious that EBV was of major interest to the LB team of
researchers.
It is also well known that EBV is a potent co-carcinogen with HIV-1
and deadly co-factor in the development of AIDS.
This 1971 report by Landon, Ting and Gallo et al., referenced the
use of “colony-born” primates observed for seroconversion to “EB
positive” immune suppressive status predisposing the animals for
retroviral infections and cancers.
To summarize this work,
conducted almost a decade before Dr. Gallo “discovered” the first
leukemia retrovirus (HTLV-I), and later HIV-1, his Bionetics
coworkers disclosed that their:
“[B]reeding and
holding colonies were surveyed for antibody to EBV. All breeders
were positive and their offspring contain maternal antibody for
several months... [Moreover,] An RNA-dependent DNA polymerase,
[the primary AIDS-linked enzyme] similar to that associated with
RNA tumor viruses, was detected in human leukemic cells but not
in normal cells stimulated by phytohemagglutinin.
The enzyme was
isolated, purified and concentrated 200-fold, making possible
its further characterization and study in relation to the leukemic process in man.”
33
This document, and
statement alone, considering its date, should be adequate impetus
for an independent investigation into the SVCP with regard to the
origin of AIDS.
Reflecting on the specific scenario advanced by Myers and co-workers
regarding the phylogenetic, recombinant, and immunosuppressive
correlates and antecedents of the “starburst” that reflects at least
ten simultaneous HIV/AIDS African outbreaks, the Bionetics
investigators stated the significance and “proposed course” of their
vaccine research involving chimpanzees.
They wrote:
“Significance to
Biomedical Research and to the [Special Virus Cancer] Program of
the [National Cancer] Institute: Inasmuch as tests for the
biological activity of candidate human [cancer] viruses will not
be tested in the human species, it is imperative that another
system be developed for these determinations and, subsequently
for the evaluation of vaccines or other measures of control.
The close
phylogenetic relationship of the lower primates [i.e.,
chimpanzees] to man justifies utilization of these animals for
these purposes. Further study of altered transfer RNA and
polymerase enzymes would determine their significance in
neoplastic change and provide a basis for selection of
therapeutic agents.
“Proposed Course: Continuation with increased emphasis on
monitoring and intensive care of inoculated animals to determine
if active infection occurs, effects of infection, and degree of
immunosuppression when used. Further studies of human neoplasms
at a molecular level will continue.”
33
Inasmuch as humans were
not being directly infected with “candidate viruses” during this
program according to the contract summary, live viral vaccines
derived from retroviruses similar to the HIVs were being prepared
and tested in primate populations that apparently included humans as
well as chimpanzees.
This at the precise time that the Australian
antigen - the HB highly infectious and easily transmissible cancer
virus - and related HB vaccines were being injected into both
chimpanzees and humans in New York and Sub-Saharan Africa by LB
collaborators.33
At the XI International Conference on AIDS in 1996, when questioned
regarding his involvement in these Bionetics studies, Dr. Gallo
angrily replied to this author,
“Quite frankly, I don’t know what
the hell you’re talking about.”13
If the HB vaccine theory might be the focus of a reputable
independent inquiry, such as the one urged by Cribb,19
and now AI members, Dr. Gallo might be obliged to formally discuss
his contract with Bionetics wherein the,
“Australian antigen was
given to newborn African green monkeys” in the context of testing “a
swarm of [candidate viral and retroviral] variants.”
If he still contends
this HB vaccine/origin of AIDS theory has no merit, as he argued
forcefully at that time, then perhaps he would be willing to publish
an alternative account reflecting more recent scientific
revelations.
Huebner et al, referred to in Bionetics’s SVCP contract
(NIH-71-2025), might also be persuaded to divulge valuable insights
regarding this HB vaccine/origin of AIDS thesis.34
At that time, 1969, Dr. Robert Huebner was also a leader in this
field on the esteemed National Academy of Sciences–National Research
Council (NAS–NRC), that is, at precisely the time the Congressional
Appropriations Committee heard testimony concerning the technical
expertise available through the NAS–NRC for the U.S. Army’s
development of AIDS-like viruses.
At that time these
viruses were referred to by military personnel in the Congressional
Record as “synthetic biological agents.” However, the scientific
community referred to them as “type-C” RNA tumor viruses. Huebner
was exquisitely aware of these developments and various retroviral
species that were routinely being generated using crude early
methods of recombination in SVCP labs. Again, these viruses were
descriptively and functionally identical to HIV-1.2,
3, 13, 14
According to the
Bionetics contract summary report from 1972, Dr. Huebner’s group
isolated and tested a cat/human hybrid oncornavirus, RD-114, from a
human sarcoma by 1971. Sarcomas, associated with leukemias and
lymphomas in AIDS patients were, at that time, unheard of in gay
men.
Later, in 1981, HB virus and vaccine expert, Dr. Don Francis,
relayed his opinion as to the source of the first GRID (AIDS) cases
in New York,
“It’s a combination of feline leukemia and hepatitis
B,” he told his mentor Max Essex at Harvard.35
The following SVCP contract excerpt34
discusses the testing of effective treatments for HIV/AIDS-like
infections at that early date:
“The effects of 11
rifamycin derivaties on viral reverse transcriptase and on DNA
polymerases from human normal and leukemic blood lymphocytes
were evaluated. Compound 143-483, 3-formyl rifamycin SV: octyl
oxime showed the greatest potency and inhibited all DNA
polymerases from both viral and cellular origins.”
Might this be a cure for
HIV/AIDS? Unless further investigations into this matter are
conducted, we may never know.
Reflecting on these revelations in-so-far-as the myriad viral
recombinants potentially contaminating LB’s labs and caged animals,
and the determinations of Myers et al,10
a most appropriate question is,
“Why only ten forms
of HIV/AIDS broke out during the early1970s?”
It would seem likely
that many of the SIVs originated from these investigations as well
as other pandemics such as herpes that exploded during the mid to
late 1970s along with immune suppressive disorders associated with
EBV infections and related cancers.
Obviously, it would be helpful
to investigate the possibility of other plagues that may have
derived from vaccine contaminations and transmissions during the SVCP.
Many researchers, in fact, issued forewarnings about the grave risks
posed by recombinant cancer virology.13
Others cited similar risks from public health’s “sacred cow”
vaccinations.31
It is sobering to
reflect on this knowledge in the wake of the Royal Society’s
publications and official evaluations.19
Considering
The Genocidal Theory of AIDS
The 1998 report of Zhu et al.9
was well timed to help promote co-author Edward Hooper’s book, The
River, which substantially reinforced a previously advanced OPV
theory of AIDS’s origin,12
and gave only superficial consideration to possible hepatitis B
vaccine contaminations as the zoonotic vector for
transferring/transforming SIVcpz into the human AIDS virus by 1976.4
Hooper referenced
Emerging Viruses: AIDS & Ebola - Nature, Accident or Intentional?
among the texts that explore the genocidal theory of AIDS which he
credited for his background on the hepatitis B theory.13
He cautioned against blanket acceptance of the intentional theory of
HIV/AIDS, which is consistent with the proposed AI investigation of
the SVCP, but he did not rule out the possibility that HIV was
released intentionally.4
As Weiss stated, theories involving the CIA in the origin of AIDS
have gained wide acceptance.6
Investigations by Horowitz et al.2,
3, 13
focused on the CIA and the 1969 appropriations hearings in which the
NAS–NRC was credited as the source of technical expertise for the
U.S. Army’s development of AIDS-like viruses.
At that time,
biological weapons were of great interest to Nelson Rockefeller’s
protégé, and Nixon administration National Security Advisor (NSA),
Dr.
Henry Kissinger.
According to his biographer, and two previous
CIA directors - William Colby and Richard Helms - Kissinger oversaw the
CIA’s top secret biological weapons program called
MK:NAOMI. Soon
after becoming NSA, he ordered a review of such weapons
capabilities.13-15
Furthermore, in the early 1970s, in keeping with U.S. Government and
global industrialists’ initiatives reflecting Rockefeller-directed
Population Council urgings for Third World depopulation, Kissinger
requested and received National
Special Security Memorandum 200
articulating the urgency of dramatically reducing African
populations.16
At that time Kissinger and associates were leading advisors to the
Merck pharmaceutical company whose president, George W. Merck, was
America’s biological weapons industry director, as he had been since
World War II.17
According to Hooper, the genocidal hypothesis of HIV/AIDS should be
“taken with a grain of salt.”
4 It is
clear, however, that compelling evidence exits, albeit
circumstantial, that U.S. Government officials, including Henry
Kissinger, may have had something to do with the initial HIV/AIDS
outbreak.
At the precise time corresponding to the earliest
transmissions of HIV/AIDS, Kissinger directed a national security cryptocracy that included corporate affiliates at the biological
weapons contractor /vaccine maker Merck, as well as the traditional
weapons contractor Litton Industries.
Litton’s president, Roy
Ash, also served in the Nixon administration overseeing American
industry. Litton’s medical subsidiary, Bionetics, as detailed above,
largely directed the NCI’s SVCP, administered America’s premier
biological weapons testing center at Fort Detrick, Maryland, and
supplied the chimpanzees, monkeys, monkey viruses, primate cell
lines, and other resources for cancer research, biological weapons
development, and vaccine manufacture.
Thus, Kissinger certainly maintained the means, through his official
channels at Merck, Litton Bionetics, and the CIA, as well as the
motive, to deploy AIDS-like viruses by 1974 in Merck’s HB vaccine.
What is unconscionable to most people, Kissinger, a staunch advocate
of African depopulation, would have considered it convenient that
the emergence of HIV/AIDS in sub-Saharan Africa coincided
synchronously with the massive depopulation policy institutionalized
with primary funding from the Rockefeller Foundation and the Merck
Fund.2,
3, 13, 14
Most recently, Kissinger’s direction of foreign genocidal operations
has been heralded by even mainstream periodicals.36
In light of these revelations, it is stunning that Kissinger wrote
his own genocide indemnification policy on behalf of the United
States Government in Foreign Affairs published by the
Council on
Foreign Relations in 2001.37
The Challenge
Before Us
“There is a crisis
of public faith in science and scientists,” stated Dr. Julian
Cribb, referring to the contentious manner in which origin
of HIV/AIDS research and debate has been conducted thus far.
“What I have described is... a systematic endeavor to suppress
public discussion and scientific inquiry into this important
[vaccine] hypothesis and to discredit its proponents over more
than 12 years.”
He summarized before the
esteemed Royal Society gathering.
“Unless scientists
are prepared to go into this issue objectively and
transparently, it will damage the standing of science in the
eyes of the community.”
19
Determining the origin
of HIV/AIDS is vital for the following reasons according to Cribb:
-
to prevent
similar calamities in the future
-
to discover
remedial methods and materials that might evolve from such
knowledge
-
to improve
safety standards in viral laboratories and vaccine
production facilities based on the knowledge of the
pandemic’s origin
-
to restore faith
and trust in this area of science and medicine
19
Furthermore, Cribb
argued,
“If AIDS is iatrogenic, through an honest mistake, science
may be forgiven. But if it seeks to bury the idea, first, it will
fail and second, it will destroy public trust.”
To the extent that
the HB vaccine theory of AIDS is officially neglected, as Hamilton
foretold:
“This hypothesis is
certainly not going to go away.”19
But if the HB vaccine
theory on the origin of AIDS, as current science overwhelmingly
supports and the “process of elimination” has virtually proven, is
ultimately accepted, then Cribb’s forgivable “honest mistake”
conjecture might need to be reexamined against more unnerving
possibilities.
At the time of this writing, the U.S. Homeland Security Act passed
the Senate virtually unanimously. Mysteriously incorporated in its
text was a vaccine injury indemnity clause that freed drug companies
from liabilities associated with specific vaccine ingredients, such
as HIV precursors in the HB vaccines. With this gross violation of
U.S. constitutional, civil, and human rights, hundreds of thousands
of Americans have been forced to care, without compensation, for
vaccine injured family members.
If the U.S. Government
is able to get away with this most blatant breach of public faith,
what is it capable of doing covertly? Clearly, this current vaccine
policy is a form of institutionalized genocide - defined as “the mass
enslaving (pharmaceutically and otherwise) and killing of people for
economics, politics, and/or ideology?”
So long as the above scientific facts and AIDS issues remain
unaddressed by medicine’s mainstream, the implications are that AIDS
science and vaccination policies, and likely all of science, has
evolved in a vacuum devoid of ethics to serve political, economic,
and/or ideological motives. Thus, by strict definition, genocide and
iatrogenesis have much.
So much so that regardless of whether
HIV/AIDS originated by accident or intentionally, with this data,
there is sufficient justification to coin a new most appropriate
term - “iatrogenocide.”
Further research to test this hypothesis should include:
-
retrospective
epidemiological studies of homosexual populations in New
York reported to have received the earliest HB vaccines
-
serological
studies of any stored blood and/or serum from these early HB
vaccine study subjects
-
likewise for the
chimpanzees used in the preliminary trials and/or vaccine
manufacture
-
genetic analyses
of viral components in samples of the vaccine lots used
during these earliest HB vaccine trials (if still
available).
References
(1) Heinrich J.
Origin of AIDS Virus. Washington, DC: U.S. General Accounting
Office, GAO-02-809R; available from
http://www.gao.gov/main.html See also: Tetrahedron
Publishing Group press release, “U.S. GAO Commits Scientific
Fraud In AIDS Inquiry: Congressional Investigators Conceal and
Lie Says Expert,” available from
healingcelebrations.com.
(2) Horowitz LG. Polio, hepatitis B and AIDS: an integrative
theory on a possible vaccine induced pandemic. Med Hypoth
2001;56(5):677-686.
(3) Horowitz LG, Strecker R, Cantwell SR, Vid, D, and Grossman
G. The Mysterious Origin of HIV: Reviewing the Natural,
Iatrogenic and Genocidal Theories of AIDS. XI International
Conference on AIDS, July 10, 1996, Vancouver, BC. Canada. See
full text of abstract and presented paper Here
(4) Hooper E. The River. Boston: Little, Brown and Company,
1999.
(5) Hamilton, WD., quoted by Julian Cribb in “The origin of
acquired immune deficiency syndrome: can science afford to
ignore it?” Phil. Trans. R. Soc. Lond. B 2001;356:935-938.
(6) Weiss, RA, Natural and iatrogenic factors in human
immunodeficiency virus transmission. Phil. Trans. R. Roc. Lond.
B 2001;356,947-953.
(7) Yusim K, Peeters M. Pybus OG and Korber B, et al. Using
human immunodeficiency virus type 1 sequences to infer
historical features of the acquired immune deficiency syndrome
epidemic and human immunodeficiency virus evolution. Phil.
Trans. R. Roc. Lond. B 2001;356,855-866.
(8) Sharp PM, Bailes E, Chaudhuri RR and Hahn BH, et al. The
origins of acquired immune deficiency syndrome viruses: where
and when? Phil. Trans. R. Roc. Lond. B 2001;356,867-876.
(9) Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM and Ho DD.
An African HIV-1 sequence from 1959 and implications for the
origin of the epidemic. Nature 1998;391(Feb. 5):594-597.
(10) Burr T, Hyman JM and Myers G. The origin of acquired immune
deficiency syndrome: Darwinian or Lamarchkian? Phil. Trans. R.
Soc. Lond. B (2001) 356:877-887; For early research regarding
the “Big Bang” theory of HIV, see also: Myers G, Macinnnes K and
Myers L. “Phogenetic moments in the AIDS epidemic.” Chapter 12
in S.S. Morse, ed., Emerging Viruses (Oxford, Eng.: Oxford
University Press, 1993).
(11) Marx PA, Alcabes PG and Drucker E.11 “Serial human passage
of simian immunodeficiency virus by unsterile injections and the
emergence of epidemic human immunodeficiency virus in Africa”
Phil. Trans. R. Soc. Lond. B (2001) 356:911-920.
(12) Elswood B and Stricker R. Polio vaccine and the origin of
AIDS. Med Hypoth 1994;42,347-354.
(13) Horowitz LG and Martin WJ. Emerging Viruses: AIDS &
Ebola - Nature, Accident or Intentional? Sandpoint, ID:
Tetrahedron Publishing Group, 1998. Note: the Hilleman
revelations concerning leukemia virus tainted yellow fever
vaccines discussed on page 485 derive from a sequestered
recorded interview conducted in 1986 by Edward
Shorter for a Merck funded documentary, “The Health Century.”
(14) Horowitz LG. Death in the Air: Globalism, Terrorism and
Toxic Warfare. Sandpoint, ID. Tetrahedron Publishing Group,
2001.
(15) Isaacson W. Kissinger. New York: Simon & Schuster, 1992, p.
205.
(16) National Security Agency. National Special Security
Memorandum 200: Implications of Worldwide Population Growth for
U.S. Security and Overseas Interests. The White House: December
10, 1974 (Declassified July 3, 1989.).
(17) Covert NM. Cutting Edge: A history of Fort Detrick,
Maryland 1943-1993. Fort Detrick , Maryland: U.S. Army Garrison,
Public Affairs Office, 1993, pp. 17, 20, 39.
(18) Plotkin SA. Untruths and consequences: the false hypothesis
linking CHAT type 1 polio vaccination to the origin of human
immunodeficiency virus. Philos Trans R Soc Lond B Biol. Sci.
2001 Jun 29:356(1410):815-823.
(19) Cribb J. The origin of acquired immune deficiency syndrome:
can science afford to ignore it? Phil. Trans. R. Soc. Lond. B
2001;356:935-938.
(20) Martin B. The burden of proof and the origin of acquired
immune deficiency syndrome. Phil. Trans. R. Soc. Lond. B
2001;356:939-938.
(21) Bliss M. Origin of AIDS (letter). The Lancet 2001;357
(January 6):73-74.
(22) Gao F, Bailes E, Shaw GM, Sharp PM and Hahn BH et al.
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.
Nature 1999 (Feb. 4);397:436-440. See also: Horowitz LG.
Response to Zhu et al. 1959 Origin of AIDS. Unpublished letter
to the editor of Nature. Available for review Here ; See also:
Horowitz L. Analysis of Gao F and Bailes E study. Unpublished
report available for review Here
(23) Poiesz B, Tomar R, Lehr B and Moore J. (along with
anonymous CDC authors). Hepatitis B vaccine: Evidence confirming
lack of AIDS transmission. MMWR 1984;33;49:685-687.
(24) Marriott SJ, Lee TH, Slagle B and Butel JS. Activation of
the HTLV-1 long terminal repeat by the hepatitis B virus X
protein. Virology 1996, 224;1:206-213.
(25) Higginson J and Muir CS. Epidemiologic program of the
International Agency for Research in Cancer (IARC) In: The
National Cancer Program and International Cancer Research,
National Cancer Institute Monograph 1974 (40:65).
(26) Jamison E and Hobbs F. World Population Profile: 1994, With
a Special Chapter Focusing on HIV/AIDS (WP/94) by Peter O. Way
and Karen A. Stanecki). Washington, DC: U.S. Government Printing
Office by the U.S. Department of Commerce, Washington, DC, 1994.
(27) Goodfield J. Quest for the Killers. Basel; Stuttgart:
Birkhauser, 1985, p. 94.
(28) Kanki PJ, Barin S, Essex M. et al. New human T-lymphotropic
retrovirus (HTLV-IV) related to simian T-lymphotropicvirus Type
III (STLV-IIIagm). Science 1986;232:238-43.
(29) Schultz TF. Origin of AIDS (letter). The Lancet
1992;339:867.
(30) Krugman S. Viral hepatitis type B: Prospects for active
immunization. In: International Symposium on Viral Hepatitis,
Milan, Dec. 1974. Develop. biol. Standard. Vol. 30, Munich: S.
Karger Basel, 1975, pp. VI; 363-367; relevant general discussion
can be found on pp.375-379; See also: Krugman S, Giles JP,
Hammond J. Hepatitis virus: effect of health on the infectivity
and antigenicity of the MS-1 and MS-2 strains. J Infectious
Disease. 1970;122:432-6; Krugman S, Giles JP, Hammond J. Viral
hepatitis, type B (MS-2 strain): Studies on active immunization.
JAMA 1971;217:41-5; Krugman S, Giles JP. Viral hepatitis, type B
(MS-2 strain); further observations on natural history and
prevention. New England Journal of Medicine 1973;288:755-60; and
Krugman S, Overby LR, Mushahwar IK, Ling C-M, Forsner GG and
Deinhardt F. Viral hepatitis, type B: Studies on natural history
and prevention reexamined. New England Journal of Medicine
1979;200:101-6.
(31) Beale J. Origin of AIDS (letter). The Lancet 2001;357
(January 6):73.
(32) Purcell RH. Current understanding of hepatitis B virus
infection and its implications for immunoprophylaxis. In:
Antiviral Mechanisms: Perspectives in Virology IX. The Gustav
Stern Symposium. New York: Academic Press, 1975, pp. 49-76.
(33) NCI staff. The Special Virus Cancer Program: Progress
Report #8 [and #9]. Office of the Associate Scientific Director
for Viral Oncology (OASDVO). J. B. Moloney, Ed., Washington, D.
C.: U. S. Government Printing Office, 1971 [and 1972]. Note:
This is a very hard publication to find. Few library data bases
have it listed, including the NCI Library at Fort Detrick. It is
available through the Davis Library, The University of North
Carolina, Chapel Hill, Government Documents Department
Depository, Reference # HE 20.3152:V81. The Litton “support
services” contracts that included primate supplies are found on
pp. 187-88 and 326-327 of the reports. Litton’s list of mutant
viruses, including retroviruses, and other experimental
infectious agents including AuAg is found on pp. 279-280 and 284
of Project Report #8, of 1971; for additional documentation on
hepatitis and herpes experimentation in Uganda before 1971 see:
Higginson J and Muir CS. Epidemiologic program of the
International Agency for Research on Cancer (IARC). In: The
National Cancer Program and International Cancer Research,
National Cancer
Institute Monograph, 1974; 40:65.
(34) Rabin H, Kinard R. Gruber J and Pearson G. Bionetics
Research Laboratories, Inc. (NIH 71-2025) Investigations of
viral carcinogenesis in primates. Here reference is made to
“Drs. McAllister, Gardiner, and Huebner” having “isolated” the
cat-human hybrid oncornavirus, RD-114, “from a human sarcoma” as
early as 1971. See reprinted contract summary in Horowitz, Op
cit. 1998, p. 429.
(35) Shilts R. The Band Played On. New York: Penguin Books,
1987, p. 107.
(36) Hitchens C. The Case Against Henry Kissinger. Harper’s
Magazine, February and March, 2001.
(37) Kissinger HA. The pitfalls of universal jurisdiction.
Foreign Affairs. July/August 2001. Preview available from
through
http://www.foreignaffaris.org.
|